Please read and agree to the
terms and conditions
of this site.
I agree
Funding Series
/tech
Clear filters and search
Format
photo
Tags
celgene
4
×
life sciences
national blog main
biotech
boston blog main
boston top stories
funding
national top stories
venture capital
boston
cancer
seattle blog main
seattle top stories
u.s. venture partners
2025
ad-comm
adverse events
affimed
akcea therapeutics
alexandria venture investments
allogene therapeutics
amicus therapeutics
approval
apremilast
astrazeneca
base editing
bill haney
bio
biogen
biome
blueprint medicineas
boulder/denver blog main
boulder/denver top stories
briefing docs
bristol meyers squibb
car-t
cervical cancer
clinical study
clinical trial
clinical trials
What
cancer
4
×
drug
drugs
immunotherapy
new
therapeutics
years
adds
ago
allogene
announced
announcing
approach
area
avoid
bio
biotech
blocking
boston
breast
celgene
class
crispr
dangerous
deal
developing
diversity
dna
effects
entrepreneur
exactly
filmmaker
funding
haney
head
hot
immunotherapies
inhibitor
investor
investors
Language
unset
Current search:
cancer
×
celgene
×
{{ ::tile.facetWhoCard }}
{{ ::tile.pubDate | moment: 'fromNow'}}
Paste
[[item:{{::tile.id}}]]
to render this photo inside an other item's description.
PROCESSING
TRANSCODING
ERROR
EXTRACTING
ERROR
{{::tile.title}}